Kyung Dong Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency
Kyung Dong Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.75 Billion ≈ $3.22 Million USD) by net assets (₩231.58 Billion ≈ $156.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Kyung Dong Pharmaceutical Co. Ltd for real-time trading data and today's change.
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained
Kyung Dong Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kyung Dong Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see 011040 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quantum Foods Holdings
JSE:QFH
|
0.032x |
|
HusCompagniet AS
CO:HUSCO
|
0.072x |
|
Flexible Solutions International Inc
NYSE MKT:FSI
|
-0.069x |
|
Magadh Sugar & Energy Limited
NSE:MAGADSUGAR
|
0.521x |
|
Starry Sea Acquisition Corp Ordinary Shares
NASDAQ:SSEA
|
-0.025x |
|
Morn Sun Feed Mill Corp
TWO:1240
|
0.009x |
|
Surf Air Mobility Inc.
NYSE:SRFM
|
0.216x |
|
Her Chee Industrial Co Ltd
TWO:8937
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. Review 011040 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩228.87 Billion ≈ $155.10 Million |
₩16.93 Billion ≈ $11.48 Million |
0.074x | +301.66% |
| 2024-12-31 | ₩220.06 Billion ≈ $149.13 Million |
₩-8.07 Billion ≈ $-5.47 Million |
-0.037x | -26148.62% |
| 2023-12-31 | ₩228.48 Billion ≈ $154.84 Million |
₩-31.94 Million ≈ $-21.64K |
0.000x | +96.66% |
| 2022-12-31 | ₩257.20 Billion ≈ $174.30 Million |
₩-1.07 Billion ≈ $-728.49K |
-0.004x | -108.74% |
| 2021-12-31 | ₩259.82 Billion ≈ $176.08 Million |
₩12.42 Billion ≈ $8.42 Million |
0.048x | -26.76% |
| 2020-12-31 | ₩262.19 Billion ≈ $177.68 Million |
₩17.12 Billion ≈ $11.60 Million |
0.065x | +632.25% |
| 2019-12-31 | ₩226.71 Billion ≈ $153.64 Million |
₩-2.78 Billion ≈ $-1.88 Million |
-0.012x | -107.81% |
| 2018-12-31 | ₩211.72 Billion ≈ $143.48 Million |
₩33.27 Billion ≈ $22.55 Million |
0.157x | +134.79% |
| 2017-12-31 | ₩220.95 Billion ≈ $149.74 Million |
₩14.79 Billion ≈ $10.02 Million |
0.067x | -45.18% |
| 2016-12-31 | ₩209.93 Billion ≈ $142.26 Million |
₩25.63 Billion ≈ $17.37 Million |
0.122x | +37.17% |
| 2015-12-31 | ₩205.14 Billion ≈ $139.02 Million |
₩18.26 Billion ≈ $12.37 Million |
0.089x | -25.43% |
| 2014-12-31 | ₩190.43 Billion ≈ $129.05 Million |
₩22.73 Billion ≈ $15.40 Million |
0.119x | +22.85% |
| 2013-12-31 | ₩169.03 Billion ≈ $114.55 Million |
₩16.42 Billion ≈ $11.13 Million |
0.097x | -25.16% |
| 2012-12-31 | ₩153.76 Billion ≈ $104.20 Million |
₩19.96 Billion ≈ $13.53 Million |
0.130x | -25.02% |
| 2011-12-31 | ₩150.62 Billion ≈ $102.07 Million |
₩26.08 Billion ≈ $17.67 Million |
0.173x | -- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more